Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Loans and Notes Receivables (2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 3 years of Loans and Notes Receivables data on record, last reported at $8.0 million in Q2 2025.

  • For Q2 2025, Loans and Notes Receivables changed N/A year-over-year to $8.0 million; the TTM value through May 2025 reached $8.0 million, changed N/A, while the annual FY2025 figure was $8.0 million, N/A changed from the prior year.
  • Loans and Notes Receivables reached $8.0 million in Q2 2025 per LFCR's latest filing, roughly flat from $8.0 million in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $8.0 million in Q1 2025 and bottomed at $8.0 million in Q1 2025.